$AEHR

SLAYEN HOWARD T sold $758K of AEHR

SLAYEN HOWARD T (Director) sold 5,700 shares of AEHR TEST SYSTEMS (AEHR) at $133.03 ($0.76M total) on 2026-08-14.

Original reporting
SEC EDGAR · SLAYEN HOWARD T
Published Aug 14, 2026, 9:52 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 10:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AEHR
Neutral
medium confidence
Mentioned
$AEHR
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

This provides a fresh datapoint on insider behavior but does not disclose new operational, financial, or regulatory information about AEHR.

02

Market read

Traders may briefly reassess sentiment around AEHR due to insider selling, but there is no fundamental catalyst in the text.

03

What to watch

The filing does not state motivations, and the transaction is an open-market sale. Also, insider selling can occur alongside positive fundamentals, so traders should watch for follow-on Form 4 patterns rather than react once.

Relevance 5/10Novelty 3/10Timing: filed on 2026-08-14, after-hours SEC Form 4 disclosure

Background

The article is an SEC Form 4 insider transaction disclosure for AEHR, reported as an open-market sale by a director.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

Director Slayen Howard T filed an open-market sale of 5,700 AEHR shares for about $758K on 2026-08-14.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and should fade unless follow-on selling appears.

Evidence & confidence

The filing is a Form 4 insider transaction, but it does not include new company fundamentals, guidance, or regulatory/contract events. The absence of a 10b5-1 plan can increase interpretive noise, yet the disclosed size is not large enough to imply a structural shift by itself.

Market effects

No clear sector read-through; this is company-specific insider activity without operational or regulatory linkage.

None indicated.

None indicated.

Counterpoint

Insider sales can be planned for liquidity or diversification; without evidence of broader selling or performance deterioration, the signal may be overstated.

Key entities

  • AEHR TEST SYSTEMS

    Subject of the Form 4 insider transaction disclosure.

  • SLAYEN HOWARD T

    Director who sold 5,700 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AEHRHighAI 8/10

AEHR Stock Rips On AI Orders And Bullish Jefferies Call

Aehr Test Systems (NASDAQ: AEHR) rose about 7% after upbeat earnings and strong semiconductor test demand. The article cites a $22M AI follow-on production order and a Jefferies Buy call with a $175 price target. It also notes quarterly revenue of about $18.84M, gross margin 35.3%, and $116.36M cash.

$AEHRMed

Aehr Test Systems Soars Again Friday. Shares Now Up More than 500% On the Year.

Jefferies initiated coverage of Aehr Test Systems (AEHR) with a Buy rating and $175 price target, citing a conservative model based on existing production and backlog. The stock rose about 8% midday and is up over 510% YTD, after AI-driven semiconductor testing demand. Peers TER, COHU, FORM, and ONTO also gained; AEHR faces valuation and revenue volatility risks.

$AEHRHighAI 9/10

Why is Aehr Test Systems stock surging today?

Investing.com reports Aehr Test Systems (AEHR) shares rose 10.7% after the company said it received a $22 million follow-on production order from a lead wafer-level AI processor customer. The order covers FOX-XP burn-in systems, FOX WaferPak contactors, and Auto Aligners. AEHR also reported fiscal Q4 2026 profit of $0.11 EPS on ~$18.8M revenue and guided fiscal 2027 revenue to $130–$150M.

$AEHRMedAI 8/10

A $22 Million Reason Why AEHR Stock Is Up Today

Aehr Test Systems (AEHR) shares rose Aug. 12 after the company said it received a $22 million follow-on production order from its lead AI processor customer for automated wafer-level test systems. The order covers FOX-XP WLBI systems and related components, shipping over six months for installation in Taiwan. Investors cited demand tied to AI chip manufacturing; AEHR trades around 212x forward earnings and has a mean $115 price target.